Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7257216

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
1,133,000 JPY
72,000 JPY
5,280,000 JPY
15,408,000 JPY
2,504,000 JPY
Ordinary profit (loss)
-1,147,879,000 JPY
-1,158,929,000 JPY
-1,473,774,000 JPY
-1,481,945,000 JPY
-1,738,636,000 JPY
Profit (loss)
-1,151,149,000 JPY
-1,168,082,000 JPY
-1,485,633,000 JPY
-1,484,192,000 JPY
-1,719,634,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
1,199,869,000 JPY
650,661,000 JPY
362,185,000 JPY
6,700,382,000 JPY
6,459,712,000 JPY
Total number of issued shares
90,491,300 xbrli:shares
70,741,300 xbrli:shares
62,891,200 xbrli:shares
55,253,100 xbrli:shares
50,817,500 xbrli:shares
Net assets
924,987,000 JPY
978,987,000 JPY
1,567,541,000 JPY
2,531,475,000 JPY
3,537,642,000 JPY
Total assets
1,120,612,000 JPY
1,230,257,000 JPY
1,701,444,000 JPY
2,771,202,000 JPY
3,749,428,000 JPY
Net assets per share
9.98
13.52
24.60
45.40
69.10
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-14.12
-18.21
-24.90
-28.55
-36.14
Diluted earnings per share
Equity-to-asset ratio
0.806 xbrli:pure
0.777 xbrli:pure
0.909 xbrli:pure
0.905 xbrli:pure
0.937 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,250,359,000 JPY
-1,156,920,000 JPY
-1,204,401,000 JPY
-1,512,022,000 JPY
-1,769,848,000 JPY
Net cash provided by (used in) investing activities
-1,370,000 JPY
-7,648,000 JPY
-1,760,000 JPY
-17,566,000 JPY
-36,211,000 JPY
Net cash provided by (used in) financing activities
1,004,840,000 JPY
690,959,000 JPY
432,104,000 JPY
569,226,000 JPY
2,053,090,000 JPY
Cash and cash equivalents
810,470,000 JPY
1,057,360,000 JPY
1,530,969,000 JPY
2,305,026,000 JPY
3,265,388,000 JPY
Number of employees
1 xbrli:pure
24 xbrli:pure
24 xbrli:pure
32 xbrli:pure
38 xbrli:pure
44 xbrli:pure
Average number of temporary employees
1 xbrli:pure
1 xbrli:pure
4 xbrli:pure
1 xbrli:pure
6 xbrli:pure
4 xbrli:pure
Total shareholder return
0.203 xbrli:pure
0.309 xbrli:pure
0.793 xbrli:pure
0.475 xbrli:pure
0.899 xbrli:pure
Total return on share price index
1.051 xbrli:pure
1.204 xbrli:pure
1.209 xbrli:pure
1.274 xbrli:pure
1.940 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.